Table 3 Effects of admission blood glucose on 30-day mortality after adjusting for confounders.

Outcome	ABG	Nonadjusted model	Adjusted model I^b	Adjusted model II^c
Total (n = 247)	mmol/L^a	1.401 (1.251–1.568) < 0.0001	1.277 (1.097–1.485) 0.0016	1.295 (1.065–1.575) 0.0097
	< 8.69 mmol/L	1.0	1.0	1.0
	≥ 8.69 mmol/L	5.233 (3.023–9.058) < 0.0001	3.308 (1.619–6.758) 0.0010	3.641 (1.579–8.394) 0.0024
Nondiabetes (n = 221)	mmol/L^a	1.514 (1.321–1.734) < 0.0001	1.317 (1.104–1.571) 0.0022	1.266 (1.036–1.547) 0.0210
	< 8.69 mmol/L	1.0	1.0	1.0
	≥ 8.69 mmol/L	6.300 (3.489–11.375) < 0.0001	3.481 (1.646–7.365) 0.0011	3.492 (1.509–8.077) 0.0035
Diabetes (n = 26)	mmol/L^a	1.527 (1.021–2.282) 0.0392	Inf (0.000–inf) 0.9988	29.984 (0.000–inf) 0.9999
	< 8.69 mmol/L	1.0	1.0	1.0
	≥ 8.69 mmol/L	Inf (0.000–inf) 0.9956	Inf (0.000–inf) 0.9980	107.132 (0.000–Inf) 0.9999

Data are expressed as OR (95% CI) P value.
^aUnit odds ratio (OR), indicating the increase in OR for every 1-unit increase in ABG.
^bAdjusted for hemorrhagic volume, rostrocaudal and intraventricular extension, hydrocephalus.
^cAdjusted for age, hypertension, body temperature, heart rate, systolic BP, abnormal respiration, GCS score, pupillary light reflex, hemoglobin, white blood cell, creatinine, hemorrhagic volume, rostrocaudal and intraventricular extension, hydrocephalus, and also adjusted for diabetes in total patients.

Quick links

Search